Imunon, Inc.·4

Jul 21, 4:17 PM ET

Tardugno Michael H 4

4 · Imunon, Inc. · Filed Jul 21, 2026

Research Summary

AI-generated summary of this filing

Updated

Imunon (IMNN) Executive Chairman Michael H. Tardugno Receives Award

What Happened
Michael H. Tardugno, Executive Chairman of the Board and a director of Imunon, Inc. (IMNN), was granted 4,603 shares on July 17, 2026 at an attributable price of $1.83 per share, representing $8,423 in total value. This transaction is coded as an award/grant (A) and reflects compensation rather than an open-market purchase.

Key Details

  • Transaction date: July 17, 2026; Filing date: July 21, 2026 (Form 4 filed on time).
  • Shares granted: 4,603; Price used: $1.83; Total value ≈ $8,423.
  • Shares owned after transaction: Not reported in this filing.
  • Footnote: Stock was granted in lieu of cash for base salary.
  • Transaction type code: A (award/grant) — not a purchase (P) or sale (S).

Context
Grants issued in lieu of cash are a form of compensation and do not necessarily indicate the insider’s buying or selling conviction about the company’s stock. For retail investors, awards like this are informative about executive compensation practices but are less direct signals of insider sentiment than open-market purchases or sales.

Insider Transaction Report

Form 4
Period: 2026-07-17
Tardugno Michael H
DirectorExecutive Chairman of Board
Transactions
  • Award

    Common Stock

    [F1]
    2026-07-17$1.83/sh+4,603$8,42368,999 total
Holdings
  • Common Stock

    (indirect: By IRA)
    4,622
Footnotes (1)
  • [F1]Stock granted in lieu of cash for base salary
Signature
/s/ Susan Eylward, Attorney-in-Fact for Michael Tardugno|2026-07-21

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4